alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Annual Report of SecureD Services, Inc. (the
"Company") on Form 10-KSB for the period ending December 31, 2003 as filed with
the Securities and Exchange Commission ("SEC") on the date hereof (the
"Report"), I, King T. Moore, Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. ss.1350, as adopted pursuant to ss.906 of the
Sarbanes-Oxley Act of 2002, that:

      (1) The Report fully complies with the requirements of section 13(a) or
      15(d) of the Securities Exchange Act of 1934; and

      (2) The information contained in the Report fairly presents, in all
      material respects, the financial condition and results of operations of
      the Company.

      A signed original of this written statement has been provided to the
Company and will be retained by the Company and furnished to the SEC or its
staff upon request.


/s/ King T. Moore
-----------------
King T. Moore
Chief Executive Officer

March 30, 2004
magex10-4_20100328.htm












EXHIBIT 10.4





Magnetek, Inc.


Non-Qualified Stock Option Agreement







FOR GOOD AND VALUABLE CONSIDERATION, MAGNETEK, INC., a Delaware corporation, hereby irrevocably grants to the Optionee named below the non-qualified stock option (the “Option”) to purchase any part or all of the specified number of shares of its $0.01 par value Common Stock upon the terms and subject to the conditions set forth in this Agreement, at the specified purchase price per share without commission or other charge.  The Option is granted pursuant to the plan specified below (the “Plan”) and the standard terms and conditions (“Standard Terms and Conditions”) promulgated under such Plan.  The terms of the Plan and the Standard Terms and Conditions are hereby incorporated herein by reference and made a part of this Agreement.  The Compensation Committee shall have the power to interpret this Agreement.








	
The Plan

	
Second Amended and Restated 2004 Stock Incentive Plan of Magnetek, Inc., November 5, 2009


	
Name of Optionee:

	  
	  	  
	
Social Security Number:

	  
	  	  
	
Number of Shares covered by Option:

	  
	  	  
	
Grant Date:

	  
	  	  
	
Purchase Price Per Share:

	  
	  	  
	
Minimum Number of Shares Per Partial Exercise:

	
100 Shares












The Option shall vest and become exercisable in installments as follows:







Until ____________, the Option shall not be exercisable to any degree.







As of ______________, the Option shall become exercisable as to 25% of the Shares covered by the Option.







As of ______________, the Option shall become exercisable as to an additional 25% of the Shares covered by the Option.







As of ________________, the Option shall become exercisable as to an additional 25% of the Shares covered by the Option.







As of ______________, the Option shall become exercisable as to the remaining 25% of the Shares covered by the Option.







Option Term:     10 years from the Grant Date.







The Option exercise price may be paid in the form of one or more of the following:  (i) cash or certified or cashiers’ check, (ii) delivery of shares of Common Stock or other property deemed acceptable by the Committee; or (iii) a reduction in the number of Shares issuable pursuant to the Option.  Unless otherwise specified by the Committee, Optionee may, upon termination of employment, exercise the vested, unexercised portion of the Option within 90 days after his or her employment termination date.  The Option may not be sold, assigned, conveyed, gifted, pledged, hypothecated or otherwise transferred in any manner prior to the vesting or lapse of all restrictions, other than by will or the laws of descent and distribution or pursuant to a “domestic relations order” as defined in the Internal Revenue Code of 1986, as amended.















	
 


MAGNETEK, INC.

	  	
 


OPTIONEE


	  	  	  	  
	
By:

	  	  	  
	  	
[Name]

	  	
Name:


	  	
President and Chief Executive Officer

	  	  
	  	  	  	  
	
By:

	  	  	  
	  	
[Name]

	  	
Address


	  	
Vice President Legal Affairs

	  	  
	  	
and Corporate Secretary
III 

113TH CONGRESS 

2D SESSION S. RES. 350 

Designating February 14, 2014, as National Solidarity Day for 

Compassionate Patient Care. 

IN THE SENATE OF THE UNITED STATES 

FEBRUARY 6, 2014 

Mr. BOOKER (for himself, Mr. MENENDEZ, and Mr. KIRK) submitted the 

following resolution; which was referred to the Committee on the Judiciary 

FEBRUARY 12, 2014 

Committee discharged; considered, amended, and agreed to with an amended 

preamble 

RESOLUTION 

Designating February 14, 2014, as National Solidarity Day 

for Compassionate Patient Care. 

Whereas National Solidarity Day for Compassionate Patient 

Care promotes national awareness of the importance of 

compassionate and respectful relationships between 

health care professionals and their patients; 

Whereas on February 14 of each year, medical professionals 

and students stand in solidarity to support compassion in 

health care as expressed by Dr. Randall Friese, triage 

physician at the University of Arizona Medical Center, 

who stated that the most important treatment he provided to Congresswoman Gabrielle Giffords after she was 


rfrederick on DSK6VPTVN1PROD with BILLS
2 

•SRES 350 ATS 

shot on January 8, 2011, was to hold her hand and reassure her that she was in the hospital and would be cared 

for; 

Whereas physicians, nurses, and all other health care professionals are charged with practicing medicine as both an 

art and a science; 

Whereas an awareness of the importance of compassion in 

health care encourages health care professionals to be 

mindful of the need to treat the patient rather than the 

disease; 

Whereas scientific research reveals that when health care professionals practice humanistically and demonstrate the 

qualities of integrity, compassion, altruism, respect, empathy, and service, their patients have better medical outcomes; and 

Whereas February 14th would be an appropriate day to designate as National Solidarity Day for Compassionate Patient Care and for health care students and professionals 

to celebrate by performing humanistic acts of compassion 

and kindness toward patients, families of patients, and 

health care colleagues: Now, therefore, be it 

1 Resolved, That the Senate— 

2 (1) designates February 14, 2014, as National 

3 Solidarity Day for Compassionate Patient Care; 

4 (2) recognizes the importance and value of a re5 spectful relationship between health care profes6 sionals and their patients as a means of promoting 

7 better health outcomes; and 


rfrederick on DSK6VPTVN1PROD with BILLS
3 

•SRES 350 ATS 

1 (3) encourages all health care professionals to 

2 be mindful of the importance of both— 

3 (A) being humane and compassionate; and 

4 (B) providing technical expertise. 

Æ 


rfrederick on DSK6VPTVN1PROD with BILLS
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Labor

###### Employment and Training Administration

                    In accordance with Section 223 of the Trade Act of 1974, as amended (19 U.S.C. 2273) (Act) the Department of Labor (Department) herein presents summaries of negative determinations on reconsideration regarding eligibility to apply for Trade Adjustment Assistance for workers by case (TA-W-) number regarding negative determinations issued during the period of February 13, 2011 through October 21, 2011. Notices of negative determinations were published in the                     **Federal Register**                     and on the Department's Web site, as required by Section 221 of the Act (19 U.S.C. 2271). As required by the Trade Adjustment Assistance Extension Act of 2011 (TAAEA), all petitions that were denied during this time period were automatically reopened. The reconsideration investigation revealed that the following workers groups have not met the certification criteria under the provisions of TAAEA.                

After careful review of the additional facts obtained, the following negative determinations on reconsideration have been issued.

TA-W-80,112; STK, LLC, Lemont Furnace, PA.

TA-W-80,112A; STK, Inc, Coconut Creek, FL.

TA-W-80,430; Product Dynamics Ltd, Levittown, PA.

                    I hereby certify that the aforementioned negative determinations on reconsideration were issued on January 30, 2012 through February 2, 2012. These determinations are available on the Department's Web site at                     *tradeact/taa/taa_search_form.cfm*                     under the searchable listing of determinations or by calling the Office of Trade Adjustment Assistance toll-free at 888-365-6822.                

Dated: February 10, 2012.

Del Min Amy Chen,

Certifying Officer, Office  of Trade Adjustment Assistance.

[FR Doc. 2012-3921 Filed 2-17-12; 8:45 am]

BILLING CODE 4510-FN-P
Exhibit
      31.1





CERTIFICATION




I,
      James
      G. Reindl, certify that:




1.
      I have
      reviewed this Quarterly Report on Form 10-QSB/A for the quarter ended September 30,
      2006, of Techprecision Corporation;




2.
      Based
      on my knowledge, this report does not contain any untrue statement of a material
      fact or omit to state a material fact necessary to make the statements made,
      in
      light of the circumstances under which such statements were made, not misleading
      with respect to the period covered by this report;




3.
      Based
      on my knowledge, the financial statements, and other financial information
      included in this report, fairly present in all material respects the financial
      condition, results of operations and cash flows of the registrant as of, and
      for, the periods presented in this report;




4.
      The
      registrant’s other certifying officer and I are responsible for establishing and
      maintaining disclosure controls and procedures (as defined in Exchange Act
      Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:




a)
      designed such disclosure controls and procedures, or caused such disclosure
      controls and procedures to be designed under my supervision, to ensure that
      material information relating to the registrant, including its consolidated
      subsidiaries, is made known to me by others within those entities, particularly
      during the period in which this report is being prepared;




b)
      evaluated the effectiveness of the registrant’s disclosure controls and
      procedures and presented in this report my conclusions about the effectiveness
      of the disclosure controls and procedures, as of the end of the period covered
      by this report based on such evaluation; and




c)
      disclosed in this report any change in the registrant’s internal control over
      financial reporting that occurred during the registrant’s fourth fiscal quarter
      that has materially affected, or is reasonably likely to materially affect,
      the
      registrant’s internal control over financial reporting; and




5.
      The
      registrant’s other certifying officer and I have disclosed, based on our most
      recent evaluation of internal control over financial reporting, to the
      registrant’s auditors and the audit committee of the registrant’s board of
      directors:




a)
      all
      significant deficiencies and material weaknesses in the design or operation
      of
      internal control over financial reporting which are reasonably likely to
      adversely affect the registrant’s ability to record, process, summarize and
      report financial information; and




b)
      any
      fraud, whether or not material, that involves management or other employees
      who
      have a significant role in the registrant’s internal control over financial
      reporting.




Dated:
                June 13, 2007
            
            /s/ James
                G. ReindlJames
                G. ReindlChief
                Executive Officer
An official website of the United States government         Here's how you know         
**Official websites use .mil**
A **.mil** website belongs to an official U.S. Department of Defense organization in the United States.
**Secure .mil websites use HTTPS**
 A **lock (lock )** or **https://** means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.

Skip to main content (Press Enter).

Defense Logistics AgencyThe Nation's Combat Logistics Support Agency

Search
Search

Search

-  Home		 
-  What DLA Offers    -  Excess Property Disposal             
  -  Document Services             
  -  Products             
  -  Services             
  -  Programs 
-  Working With DLA    -  Applications             
  -  Small Business             
  -  Federal and International Cataloging             
  -  Defense Data Standards             
  -  Events             
  -  Procurement Policies             
  -  Government Programs             
  -  Forms 
-  Organizations    -  DLA Headquarters             
  -  DLA Aviation             
  -  DLA Disposition Services             
  -  DLA Distribution             
  -  DLA Energy             
  -  DLA Land and Maritime             
  -  DLA Troop Support             
  -  DLA CENTCOM & SOCOM             
  -  DLA Europe & Africa             
  -  DLA Indo-Pacific 
-  Customer Support    -  Self Help Tools             
  -  How to Order             
  -  Find Your Order             
  -  Customer Facing Offices             
  -  Training             
  -  Brochures             
  -  Warfighter Support             
  -  Customer Service Management 
-  Careers		 
-  About DLA    -  Contact Us             
  -  Locations             
  -  Leaders             
  -  News             
  -  History             
  -  Media Gallery             
  -  DLA Campaigns 

HomeAbout DLAImages

# DLA Images

Search

Search

                                  - All Images 
                                  - Other 

                                  - Upload Date
                                  - Photo Date
                                  - Title

Share

----

Download Image: Small ()Medium ()Full Size (1.84 MB)

Tags:Combat Logistics Regiment 25

Photo by:VIRIN: 

Photo Gallery
Exhibit 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER, SECTION 906

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Venugopal Rathi, the Chief Financial Officer (Principal Financial Officer) of TCG BDC, Inc. (the Company), hereby certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| |  |  | the Form 10-Q of the Company for the quarter ended March 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the Form 10-Q), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------------------------



Dated: May 10, 2017/s/ Venugopal RathiVenugopal Rathi
Chief Financial Officer
(Principal Financial Officer)




|* | The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.
|- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------
##### 



Exhibit 32.1
 CERTIFICATION OF CHIEF EXECUTIVE OFFICER,
AS REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.
  (i)
    
    The accompanying annual report on Form 10-K
for the year ended December 31, 2005 fully
complies with the requirements of Section
13(a) or Section 15(d) of the Securities
Exchange Act of 1934, as amended; and(ii)
    
    The information contained in such report
fairly presents, in all material respects,
the financial condition and results of
operations of Laserscope.
 Date: March 15, 2006/s/ Eric M. ReuterEric M. ReuterChief Executive Officer
(Principal Executive Officer)
EXHIBIT 32.2


                             CERTIFICATION

     Pursuant  to  Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C.1350,
as  adopted), Steven Gidumal, Chief Financial Officer of Golden Gate Homes, Inc.
(the  "Company"),  hereby  certifies  that,  to  the  best  of  his  knowledge:

     1.  The  Company's Quarterly Report on Form 10-Q for the period ended March
31,  2010,  to  which  this  Certification  is  attached  as  Exhibit  32.2 (the
"Quarterly  Report")  fully  complies  with the requirements of Section 13(a) or
Section  15(d)  of  the  Securities  Exchange  Act  of  1934,  and

     2.  The  information  contained in the Quarterly Report fairly presents, in
all  material respects, the financial condition and results of operations of the
Company.

      IN WITNESS WHEREOF, the undersigned has set his hands hereto as of May 11,
2010.

                    /s/  Steven  Gidumal
                    --------------------
                         Steven  Gidumal
             Chairman  of  the  Board  of  Directors
                and  Chief  Financial  Officer
          (Principal  Financial  and  Accounting  Officer)
Amendment No. 10 (#2) to Lease and License Agreement, dated 09/29/2009



 Exhibit 10.25 

MARYLAND TECHNOLOGY DEVELOPMENT CENTER 

LICENSE AGREEMENT 

AMENDMENT 10 
 This
addendum is made this 29th day of September, 2009, by and between MEDCO and Neogenix Oncology, Inc. ("Licensee"). 
 WHEREAS,
MEDCO and Licensee have entered into a License Agreement dated April 28, 2004; 
 WHEREAS, Licensee currently occupies Labs
#211, #222 and #226, and offices #261, #262, #267 and #317 in the Maryland Technology Development Center in Montgomery County, Maryland (the "Original Premises"); 

WHEREAS Licensee wishes to expand its office space within the Maryland Technology Development Center and MEDCO is willing to provide for
such expansion based on the terms provided for below; 
 NOW, THEREFORE, in consideration of the mutual covenants and agreements
stated herein, the parties agree as follows: 
  

	 	1.	Effective October 15, 2009, Licensee shall occupy office #260 (the "Expansion Premises"). 


 

	 	2.	The Monthly Payment, for the Expansion Premises, provided herein shall be as follows: 


 

				
	 From October 15, 2009 to October 31, 2009
	  	$	178
	 From November 1, 2009 to April 30, 2010
	  	$	345

  

	 	3.	The aggregate Monthly Payment, to include the Monthly Payment for the Original Premises and the Reduction Premises provided for herein shall be as follows:


  

				
	 From November 1, 2009 to April 30, 2010
	  	$	14,499
		
	 Renewal Term (if granted by MEDCO) From May 1, 2010 to April 30, 2011
	  	$	14,499

  

	 	4.	All other provisions of the original License Agreement shall apply to this Amendment 








 This Amendment may be signed in counterparts. 

 

									
	FOR:	 	 Maryland Economic
 Development
Corporation
	 		 	FOR:	 	Neogenix Oncology, Inc.
					
	BY:	 	
 



	 		 	BY:	 	
 




		 	 Scheer Partners, Inc.

Center Manager
	 		 		 	
					
	Date:	 	9/29/09	 		 	Date:	 	9.28.09
					
	BY:	 	 /s/ Robert C. Brennan
	 		 		 	
		 	 Robert C. Brennan
 Executive
Director, MEDCO
	 		 		 	
					
	Date:	 	10/15/09
VI 

111TH CONGRESS 

1ST SESSION S. 124 

For the relief of Shigeru Yamada. 

IN THE SENATE OF THE UNITED STATES 

JANUARY 6, 2009 

Mrs. FEINSTEIN introduced the following bill; which was read twice and 

referred to the Committee on the Judiciary 

A BILL 

For the relief of Shigeru Yamada. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. PERMANENT RESIDENT STATUS FOR SHIGERU 

4 YAMADA. 

5 (a) IN GENERAL.—Notwithstanding subsections (a) 

6 and (b) of section 201 of the Immigration and Nationality 

7 Act (8 U.S.C. 1151), Shigeru Yamada shall be eligible for 

8 issuance of an immigrant visa or for adjustment of status 

9 to that of an alien lawfully admitted for permanent resi10 dence upon filing an application for issuance of an immi11 grant visa under section 204 of that Act (8 U.S.C. 1154) 

12 or for adjustment of status to lawful permanent resident. 


jbell on PROD1PC69 with BILLS
2 

•S 124 IS

1 (b) ADJUSTMENT OF STATUS.—If Shigeru Yamada 

2 enters the United States before the filing deadline speci3 fied in subsection (c), Shigeru Yamada shall be considered 

4 to have entered and remained lawfully and shall be eligible 

5 for adjustment of status under section 245 of the Immi6 gration and Nationality Act (8 U.S.C. 1255) as of the date 

7 of the enactment of this Act. 

8 (c) APPLICATION AND PAYMENT OF FEES.—Sub9 sections (a) and (b) shall apply only if the application for 

10 issuance of an immigrant visa or the application for ad11 justment of status is filed with appropriate fees not later 

12 than 2 years after the date of the enactment of this Act. 

13 (d) REDUCTION OF IMMIGRANT VISA NUMBERS.— 

14 Upon the granting of an immigrant visa or permanent res15 idence to Shigeru Yamada, the Secretary of State shall 

16 instruct the proper officer to reduce by 1, during the cur17 rent or subsequent fiscal year, the total number of immi18 grant visas that are made available to natives of the coun19 try of birth of Shigeru Yamada under section 203(a) of 

20 the Immigration and Nationality Act (8 U.S.C. 1153(a)) 

21 or, if applicable, the total number of immigrant visas that 

22 are made available to natives of the country of birth of 

23 Shigeru Yamada under section 202(e) of that Act (8 

24 U.S.C. 1152(e)). 

Æ 


jbell on PROD1PC69 with BILLS